Curr Med Res Opin 24(1):275286 Kong F, Wu T, Dai J, Zhai Z, Cai J, Zhu Z et al (2023) Glucagon-like peptide 1 (GLP-1) receptor agonists in experimental Alzheimers disease models: a systematic review and meta-analysis of preclinical studies
Balagtas, et al., 2024
Have a subject youd like us to cover in a future article
Significant Results : More substantial weight loss typically occurs after 12-16 weeks of consistent use
Abbreviations MMT : Mixed meal test PBH : Post-bariatric hypoglycemia RYGB : Roux-en-Y Gastric Bypass GLP-1 : Glucagon-like Peptide 1 FGF-19 : Fibroblast growth factor 19 FGF-21 : Fibroblast growth factor 21 References hrstrm CC, Worm D, Hansen DL
Keep in mind that aside from GLP-1 drugs, comprehensive obesity care can include behavioral health therapy, medically managed weight loss programs, lower-cost weight loss medications and even surgery